Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 4:00 PM
Ignite Modification Date:
2025-12-26 @ 4:00 PM
NCT ID:
NCT02006706
Eligibility Criteria:
Inclusion Criteria:
* adult patients, 18-80 years of age;
* rheumatoid arthritis after inadequate response to \>=1 DMARD treatment;
* active disease;
* DMARDs other than methotrexate withdrawn for at least 4 weeks prior to start of study treatment.
Exclusion Criteria:
* autoimmune disease other than rheumatoid arthritis;
* bone/joint surgery within 8 weeks prior to screening, or joint surgery planned within 24 weeks of MabThera infusion;
* concurrent treatment with any DMARD or antiTNF-alfa;
* intra-articular or parenteral corticosteroids within 4 weeks prior to screening.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02006706
Study Brief:
Protocol Section:
NCT02006706